Corporate News 29-Oct-22
Neogen Chemicals to declare Quarterly Result
On 5 November 2022
Neogen Chemicals will hold a meeting of the Board of Directors of the Company on 5 November 2022.
Previous News
Neogen Chemicals consolidated net profit rises 51.36% in the September 2021 quarter
( Results - Announcements 01-Nov-21 08:14 )
Neogen Chemicals to convene board meeting
( Corporate News - 31-Jul-23 15:02 )
Neogen Chemicals standalone net profit rises 26.63% in the March 2019 quarter
( Results - Announcements 01-Jun-19 14:45 )
Neogen Chemicals standalone net profit rises 51.01% in the September 2021 quarter
( Results - Announcements 30-Oct-21 18:24 )
Neogen Chemicals to declare Quarterly Result
( Corporate News - 02-Feb-24 16:14 )
Neogen Chemicals consolidated net profit declines 8.50% in the March 2023 quarter
( Results - Announcements 15-May-23 07:39 )
Neogen Chemicals schedules board meeting
( Corporate News - 02-Mar-23 20:01 )
Neogen Chemicals receives reaffirmation in ratings for bank facilities
( Corporate News - 28-Jan-21 13:28 )
Neogen Chemicals consolidated net profit declines 12.16% in the June 2023 quarter
( Results - Announcements 07-Aug-23 07:37 )
Haridas Kanani divests 5.67% stake in Neogen Chemicals
( Corporate News - 29-Jun-24 12:22 )
Neogen Chemicals to conduct board meeting
( Corporate News - 03-Mar-23 10:47 )
Other Stories
Hinduja Global Solutions opens new CX hub in Cape Town, South Africa
03-Oct-24 10:13
Anmol India to conduct board meeting
03-Oct-24 10:07
KPI Green Energy receives CEIG approval for 5 MW solar power project
03-Oct-24 10:04
Navkar Corporation revises board meeting date
03-Oct-24 09:52
Paytm deploys card machines across 2 Krishi Mandis in Madhya Pradesh
03-Oct-24 09:52
Adani Ports records 14% growth in cargo volumes in September 2024
03-Oct-24 09:37
SignatureGlobal India launches new project in Gurugram
03-Oct-24 09:34
Biocon Biologics refinances debt through USD bonds and syndicated term loan
03-Oct-24 09:29
RattanIndia Enterprises launches woman's ethnic wear brand 'Kaari'
03-Oct-24 09:26
Alembic Pharma receives USFDA approval for Lamotrigine Extended-Release Tablets
03-Oct-24 09:23
Back
Top
